Highest-materiality recent filing
OneMedNet receives Nasdaq notice for minimum bid price non-compliance
Received Nasdaq notice on April 14, 2026 for failing $1.00 minimum bid price rule over 30 consecutive business days.
OneMedNet regains Nasdaq minimum bid price compliance; delisting risk removed
Received Nasdaq notice on Oct. 8, 2025 confirming compliance with Bid Price Rule.
OneMedNet regains Nasdaq compliance for minimum market value listing rule
Received deficiency notice on March 12, 2025 for MVLS below $35M.
OneMedNet raises $3.7M equity, converts $6.6M debt, settles $4.3M payables
Private placement raised ~$2.5M via 3.39M shares and 2.56M pre-funded warrants at $0.42/share.
OneMedNet receives Nasdaq bid price deficiency notice; 180 days to cure
Notice received April 10, 2025; common stock closing bid below $1.00 for 30 consecutive business days.
OneMedNet receives Nasdaq deficiency notice for MVLS below $35M, faces potential delisting
Nasdaq notified OneMedNet that MVLS was below $35M for 31 consecutive business days as of March 12, 2025.
OneMedNet regains Nasdaq compliance after filing overdue quarterly reports
Received Nasdaq notice confirming compliance with Listing Rule 5250(c)(1) after filing Q1-Q3 2024 Form 10-Qs.
OneMedNet receives Nasdaq delisting notice for late Q3 2024 10-Q filing
Nasdaq notice dated Nov 21, 2024: Company failed to timely file Form 10-Q for quarter ended Sep 30, 2024.
OneMedNet files Legacy Q3 2023 financials: revenue $681K, net loss $31.2M
Revenue $681K for nine months ended Sep 30, 2023, down from $889K in 2022.
OneMedNet restates FY 2023; finds errors in convertible notes, warrants, stock comp, de-SPAC
Audit Committee determined on Nov 4, 2024 that prior FY 2023 financial statements should no longer be relied upon due to errors.
OneMedNet receives Nasdaq deficiency notice for minimum bid price non-compliance
Received Nasdaq letter on Oct 16, 2024 for common stock failing minimum $1.00 bid price for 30 consecutive business days.
Nasdaq notified OneMedNet on Oct 8, 2024 that its MVLS ($35M minimum) was below threshold for 30 consecutive business days, violating Rule 5550(b)(2).
OneMedNet appoints Clarke and McCraw to board after Casey and Akyuz departures
Paul Casey and Erkan Akyuz resigned from OneMedNet board effective Oct 1, 2024; no disagreement cited.
OneMedNet closes $1.7M private placement, to use portion of proceeds to purchase Bitcoin
Gross proceeds of ~$1.7M from sale of 1,918,591 shares at $0.65, plus warrants and pre-funded warrants.
OneMedNet receives Nasdaq non-compliance notice; exception until Oct 31 to file delinquent 10-Qs
First notice for failure to timely file Form 10-Q for quarter ended June 30, 2024.
OneMedNet CFO Lisa Embree resigns; Robert Golden appointed interim CFO effective Aug 30
Lisa Embree resigned as CFO, EVP, Treasurer and Secretary effective Aug 30, 2024; notice given Aug 26.
OneMedNet receives Nasdaq notice for late 10-Q; appoints new auditor, secures $25M SEPA
Received Nasdaq delinquency notice on June 20, 2024 for late Form 10-Q; 60 days to submit plan, possible extension to Dec 11, 2024.
Up to $25M standby equity purchase agreement with Yorkville; purchases at 97% of Market Price; 24-month term; subject to conditions.
OneMedNet regains Nasdaq minimum bid price compliance, delisting risk resolved
On March 26, 2024, Nasdaq notified OneMedNet of non-compliance with $1.00 minimum bid price; 180-day cure period ran to Sep 23, 2024.
OneMedNet appoints new auditor WithumSmith+Brown after former auditor BF Borgers banned by SEC
On June 3, 2024, OneMedNet appointed WithumSmith+Brown as new independent registered public accounting firm.
OneMedNet dismisses auditor BF Borgers after SEC bars firm from practicing before Commission
BF Borgers dismissed as auditor on May 6, 2024, after SEC order (May 3) permanently barring the firm from practicing before the Commission.
the Board appointed Dr. Kenneth Alleyne to serve as a Class III Director of the Board to fill the vacancy created by the expansion of the Board.
On January 31, 2025, the Board appointed Mr. Golden as CFO of the Company on a permanent basis.
Departure of Directors : Paul Casey and Erkan Akyuz resigned from the Board, effective immediately.
Departure of Directors : Paul Casey and Erkan Akyuz resigned from the Board, effective immediately.
elected Jair Clarke to the Board as a Class II Director, effective immediately
elected Sherry Coonse McCraw to the Board as a Class III Director, effective immediately
Effective August 30, 2024, the board of directors (the “Board”) of OneMedNet Corporation (the “Company”) appointed Robert Golden to serve as Chief Financial Officer (“CFO”) on an interim basis.
Effective August 30, 2024, Lisa Embree departed as the Company’s CFO, Executive Vice President, Treasurer and Secretary.
Effective August 14, 2024, the Board appointed Mr. Andrew B. Zeinfeld, to serve as a member of the Board to fill the vacancy created by the resignation of Dr. Huh.
On August 12, 2024, Dr. Julianne (Sun Joo) Huh, a member of the Board of Directors (the “Board”) of OneMedNet Corporation (the “Company”) and a member of the Company’s Nominating and Corporate Governance Committee, notified the Company of her resignation from the Company’s Board effective August 12, 2024.
Max materiality 0.85 · Median 0.60 · Most common event other_material